PRPO (PRPO) Stock Price & Analysis
PRPO (PRPO) rose 4.90% to USD 27.4 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
PRPO last closed at USD 27.4; the session ranged USD 24.48–27.9 on volume of 114,537 shares. Market capitalization is —, with a 52-week range of USD 16–33.63 (NCM). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 27.4 |
|---|---|
| Change | ▲ 4.90% (up) |
| Previous Close | USD 27.4 |
| Open | USD 27.4 |
| Day Range | USD 24.48 – 27.9 |
| 52-Week Range | USD 16 – 33.63 |
| Volume | 114,537 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PRPO)
Nexqual's technical model rates PRPO "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.8 (neutral) |
| vs SMA50 | Above (USD 25.03) |
| MACD | 0.99 (positive) |
From PRPO's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RHEP | Regional Health Properties, Inc | USD 1.01 | ▼ 6.91% |
| CFOR | CapForce Inc. | USD 5.15 | ▲ 0% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| COCP | Cocrystal Pharma, Inc. | USD 1.13 | ▼ 2.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.